The Controversial Sale of 23andMe's Genetic Data** A significant ruling is imminent regarding the sale of 23andMe’s vast repository of genetic data—a move that has raised alarm bells across many ...

We recently compiled a list of 10 Most Undervalued Healthcare Stocks to Buy According to Analysts. Regeneron Pharmaceuticals, ...

He said it will protect consumer privacy by restricting the sale of genetic data obtained from individuals by biotech ...

Our previous report on the Chapter 11 case of 23andMe discussed the Sale Order entered by the Bankruptcy Court on June 27, ...

Me’s privacy ombudsman secured court approval to retain WilmerHale in the DNA testing company’s Chapter 11 case despite an ...

The sale of 23andMe has been finalized, transforming the once-public genetics company into a nonprofit under the leadership ...

A new genetic test, based on data from more than five million people, can identify people at risk of severe obesity. The test can be performed on children before their genetic risk starts to shape ...

After Foley Hoag’s prior updates regarding the chapter 11 bankruptcy cases of 23andMe Holding Co and its affiliated debtors ...

After a couple of months of non-stop litigation, counsel for the debtor at Paul, Weiss and for the acquirer—a newly formed ...

The new 23andMe says it will be adding additional privacy protections, but there are still concerns at the privacy of customer’s data.

DNA from 23andMe after it declared bankruptcy. Now the more than 10 million remaining customers should delete theirs, too.

TTAM Research Institute acquires 23andMe in a $305 million bankruptcy sale, transitioning the DNA testing giant to a ...